The anaphase-promoting complex (APC/C) is a multimeric RING E3 ubiquitin ligase that controls chromosome segregation and mitotic exit. Its regulation by coactivator subunits, phosphorylation, the mitotic checkpoint complex and interphase early mitotic inhibitor 1 (Emi1) ensures the correct order and timing of distinct cell-cycle transitions. Here we use cryo-electron microscopy to determine atomic structures of APC/C-coactivator complexes with either Emi1 or a UbcH10-ubiquitin conjugate. These structures define the architecture of all APC/C subunits, the position of the catalytic module and explain how Emi1 mediates inhibition of the two E2s UbcH10 and Ube2S. Definition of Cdh1 interactions with the APC/C indicates how they are antagonized by Cdh1 phosphorylation. The structure of the APC/C with UbcH10-ubiquitin reveals insights into the initiating ubiquitination reaction. Our results provide a quantitative framework for the design of future experiments to investigate APC/C functions in vivo.
The activities of the diverse proteins that orchestrate the sequential biochemical and morphological changes intrinsic to the cell division cycle are controlled through the integration of protein phosphorylation, proteolysis and changes in gene expression. Two cullin-RING E3 ubiquitin ligases, the APC/C and Skp1/Cul1/F-box (SCF), catalyse the ubiquitination of multiple cell-cycle proteins to regulate their proteasome-mediated proteolysis. By regulating the ordered degradation of substrates such as cyclins, securin, mitotic kinases, and microtubule motors and assembly factors, the APC/C controls sister chromatid segregation, cytokinesis and the initiation of chromosome duplication [1] [2] [3] . The APC/C is a large assembly comprising 19 subunits 4 . Its activity depends on the association of one of two coactivator subunits (either Cdc20 or Cdh1) that specify substrate recognition and stimulate the catalytic activity of APC/C-E2 complexes [4] [5] [6] [7] . Coactivators engage the APC/C through a conserved amino (N)-terminal C-box motif and a carboxy (C)-terminal Ile-Arg (IR) tail 2, 3 . Cyclin-dependent kinase (CDK) phosphorylates the APC/C, promoting Cdc20 association 8, 9 . In contrast, Cdh1 is negatively regulated by phosphorylation 8, 10, 11 . APC/C activity is repressed by the spindle assembly checkpoint (SAC) to ensure accurate sister chromosome segregation 3 . The SAC effector, the mitotic checkpoint complex (MCC), inhibits mitotic APC/C Cdc20 whereas Emi1 inhibits APC/C Cdh1 during interphase 12 . Similar to the MCC, Emi1 blocks destruction box (D box) recognition by APC/ C-coactivator complexes. However, Emi1 also antagonizes the two E2s, UbcH10 and Ube2S, that pair with the APC/C and which are responsible for catalysing ubiquitin chain initiation and elongation, respectively [13] [14] [15] [16] [17] . A quantitative mechanistic understanding of the APC/C requires structural information to atomic resolution. We previously described the human APC/C Cdh1 -substrate complex (APC/C Cdh1.Hsl1 ) from a cryo-electron microscopy (cryo-EM) reconstruction, allowing definition of the overall architecture of the multi-subunit assembly 4 . Still, the atomic structures of several large and most small APC/C subunits, and the regulatory N-terminal domain (NTD) of Cdh1, were unknown, which together with the flexibility of the catalytic module comprising the RING subunit Apc11 and the C-terminal domain of Apc2 (Apc2 CTD ) limited our understanding of the complex.
Here, we used recombinant APC/C Cdh1 in complex with Emi1 (APC/C Cdh1.Emi1 ) to determine an atomic model of the APC/C to 3.6 Å resolution (Extended Data Figs 1 and 2 and Extended Data Table 1 ). This structure, together with an APC/C Cdh1 -UbcH10 complex, reveals details of the initiating ubiquitination reaction and how Emi1 inhibits UbcH10 and Ube2S 13, 14 .
Atomic structure of APC/C Cdh1.Emi1 Similar to APC/C Cdh1.Hsl1 (ref. 4) , 60% of molecules are the coactivator-bound APC/C Cdh1.Emi1 complex, with the remainder in the apo state (APC/C without coactivator). APC/C Cdh1.Emi1 adopts the active conformation with the platform sub-domain, incorporating Apc2 CTD -Apc11, in the upward position (Fig. 1a) . However, in contrast with APC/C Cdh1.Hsl1 where Apc2 CTD -Apc11 is flexible 4 , Emi1 stabilizes Apc2 CTD -Apc11 by bridging it to Apc1 (Fig. 1a) . With the APC/C Cdh1.Emi1 EM map at 3.6 Å resolution, we built a complete atomic model of the complex. Existing crystal structures, complemented by newly determined structures of Apc4 and the N-terminal domain of Apc5 (unpublished data), together with homology models (Extended Data Tables 2 and 3) , were used to guide building of most large APC/C subunits. For Apc1, fitting to the N-terminal Apc1 WD40 domain and the densities N-and C-terminal to its central PC domain (Apc1 PC ) were performed ab initio. These two regions coalesce to form Apc1
Mid that connects Apc1
WD40
with Apc1 PC and comprises an a-solenoid capped by a b-sandwich (Extended Data Fig. 3a ). Apc13 and Apc16 of the tetratricopeptide repeat (TPR) lobe interact with structurally homologous symmetryrelated sites on the four TPR homo-dimers (Extended Data Fig. 3b, c) . The refined APC/C Cdh1.Emi1 model has excellent stereochemistry and is in good agreement with the EM density map (Extended Data Fig. 2 and Extended Data Table 1 ).
Cdh1
NTD binds to Apc1 and Apc8
In the APC/C Cdh1.Emi1 EM map, the Cdh1 NTD -assigned region shows clearly resolved side-chain features (Extended Data Fig. 1g ). Four distinct segments of Cdh1 NTD are organized into two mini-domains (Fig. 2a) . Segments 1 and 3 interact with Apc8B, whereas segments 2 and 4 interact with Apc1 PC . Segment 1 incorporates the seven-residue C box (residues 46-52) (Extended Data Fig. 3d ), which, through extensive contacts with Apc8, is a key determinate of Cdh1 NTD -APC/C interactions. The C box adopts a hairpin conformation that inserts into the TPR superhelix of Apc8 (Fig. 2a, b) . Asp46, Arg47 and Arg52 of the C box form a network of electrostatic interactions, whereas Phe48 and Ile49 mediate non-polar contacts. Strikingly, Arg47 and Ile49 bind a site on Apc8 that is structurally homologous to the IR tail-binding site of Apc3, a paralogue of Apc8 (Fig. 2b-d) . In both TPR proteins, three invariant residues (Asn339, Ser342 and Glu374 of Apc8) coordinate the Arg guanidinium group, with the aliphatic moiety of Arg sandwiched between a conserved aromatic residue and an invariant Leu (Fig. 2b-d) . The aliphatic side chain of Ile49 of the C box is flanked by two tyrosines (both conserved in Apc3) and a Met (Leu in Apc3). The main role of segment 3 is to stabilize the conformation of segment 1 by contributing Leu127 and Phe128 to a cluster of hydrophobic residues at the Apc8-Cdh1 NTD interface (Fig. 2a) . Mutation of both residues severely abrogates Cdh1 activity (Fig. 2e, lanes 1 and 4) . Segment 2 forms a leucine zipper-like a-helical interface with two outer a-helices of Apc1 PC , an interaction mediated by three conserved leucines (Fig. 2a) . The a-helix of segment 4 aligns antiparallel to segment 2 (Fig. 2a) . It includes the KLLR sequence (Extended Data Fig. 3d ), structurally similar to the KILR motif of Cdc20 NTD that interacts with Mad2 as a b-strand 18 , and is implicated in mediating APC/C-Cdc20 interactions 19 . Leu160 and Leu161 of the KLLR sequence, together with Val153 of segment 4, contribute to the hydrophobic interface of segment 2 and Apc1 PC (Fig. 2a, f) . L94   S1+3   S2   S4  10B 10B   10B 10B  10B 10B  10A 10A   10A 10A  10A 10A   11A 11A   11A 11A  11A 11A   12A 12A  12A 12A  12A 12A   G406  G406 G406   Apc6B  Apc6B Apc6B   H373 H373 H373   G338 G338 G338   L419  L419 L419   Apc8B Apc8B Apc8B   9A 9A   9A 9A  9A 9A   8A 8A  8A 8A  8A 8A   9B 9B   9B 9B  9B 9B   L127  F61   W57   F48   α1   α3   R47   D46   F48   I49   P50   S51  R52   Y403   E410   R400   H373   E374   S342   N339   Y308   R434   b   Y3 99   C box   L370   M435   G332  E610   N575   W544   S578   R496   I495   H609 PC interface, multiple residues cooperate to mediate APC/C-Cdh1 interactions. g, Ser40, Ser151 and Ser163 mediate the negative regulation of Cdh1 by CDK phosphorylation. Experiments in Fig. 2e , f were replicated three times and in Fig. 2g five times.
The C-terminal ten residues of Cdh1 form the IR tail. This is well ordered and adopts a mainly a-helical conformation that inserts into the TPR superhelix of Apc3A ( Fig. 2c and Extended Data Fig. 3b ). The universally invariant C-terminal Arg496 contacts residues of Apc3A analogous to how Arg47 of the C box contacts Apc8 (Fig. 2b, c) . The adjacent Ile of the IR tail packs into a hydrophobic pocket on Apc3. Through its C-terminal IR residues, Apc10 interacts with a similar conformation to the symmetry-related IR tail-binding site on the Apc3 homo-dimer (Apc3B) (Fig. 2d) .
Both C-box Arg47 and its coordinating Asn339 residue (Fig. 2b ) are required for coactivator binding to the APC/C [20] [21] [22] , and the biochemically defined interaction of Cdc20 NTD . Disruption of Apc3 residues Asn575 and Leu606 impaired coactivator binding 21 . Furthermore, temperature-sensitive cell-cycle mutations of Saccharomyces cerevisiae CDC23 (Apc8) (ref. 23 ) can be rationalized because of their disruption of the C-box receptor (Fig. 2b) . In support of these previous data, mutating Asn339 and Glu374 of Apc8 that engage Arg47 abolished the capacity of Cdh1 to activate the APC/C (Fig. 2e) . By contrast, mutation of the structurally related Arg493 of the IR tail only reduced APC/C Cdh1 activity (Extended Data Fig. 4a ). Arg52 of the C box forms a salt bridge with Glu410 of Apc8 (Fig. 2b) , and disrupting either residue eliminates APC/C activity (Fig. 2e) .
To explore the basis for the negative regulation of coactivators by CDK phosphorylation 8, 10, 11 , we first identified which of the nine potential CDK phosphorylation sites in Cdh1 NTD account for this control. Four of these sites (Ser40, Thr121, Ser151, Ser163) (Extended Data Fig. 3d ) are both necessary and sufficient to mediate CDKregulation of Cdh1 (Fig. 2g, lanes 1-6) , in agreement with ref. 24 . Although Ser40, Ser151 and Ser163 (but not Thr121) phosphorylation each contributes individually to a degree of Cdh1 inactivation (Fig. 2g, lanes 7-14) , simultaneous phosphorylation of all sites was required to inactivate Cdh1 completely (Fig. 2g, lanes 1-4) . Phosphorylation of these sites would destabilize Cdh1 NTD -APC/C interactions through electrostatic repulsion and steric clashes (Fig. 2a) . Ser40 is immediately N-terminal to the C box, whereas the side chains of Ser151 and Ser163 flank the KLLR sequence of segment 4 and contact Apc1 PC (Fig. 2a ).
Emi1 inhibits UbcH10 and Ube2S binding
Four functional elements of Emi1 mediate APC/C Cdh1 inhibition 13, 14, 25 . A D-box motif that occludes substrate recognition is connected through a linker to a zinc-binding region (ZBR) (Emi1 ZBR ) that interferes with UbcH10-dependent APC/C activity 13, 14, 25 . A C-terminal LRRL sequence (LR tail: Emi1 LR ), identical to the LRRL motif required for Ube2S association with the APC/C 4,7,14 , antagonizes Ube2S 13, 14 . In the APC/C Cdh1.Emi1 structure, we identified EM density corresponding to all four elements (Fig. 3a, b ). This agrees with a previous EM study at lower resolution that had assigned Emi1 density bridging the substrate recognition module and platform 13 . In our structure, the Emi1 D box is engaged by the D-box co-receptor of Cdh1 and Apc10 (Figs 1a and 3a) . We identified EM density matching the in-between-RING (IBR) architecture of Emi1 ZBR (ref. 13) associated with Apc2 CTD -Apc11 (Fig. 3a, b) . The domain connects these subunits to an insertion within Apc1 PC . In the EM map, part of the Emi1
Linker forms an a-helix that packs against the Emi1 ZBR b-sheet and docks onto the UbcH10 binding site of Apc11 RING (Fig. 3a, b ). This blocks UbcH10 association with Apc11 RING . We assigned Emi1
LR as a helical density feature to a site on Apc2
CTD at the interface of its four-helix bundle and a/b sub-domain, adjacent to Apc4 WD40 ( Fig. 3b and Extended Data Fig. 2f ), and in agreement with biochemical studies 14, 26 . Emi1
ZBR does not contribute to inhibiting Ube2S-catalysed ubiquitination reactions 13, 14 , and our structure shows that Ube2S-specific sites on Apc11 RING (ref. 26) are not blocked by Emi1 ZBR (Fig. 3b) RING is repurposed to position the acceptor ubiquitin for modification by the Ube2S-ubiquitin conjugate 26 . To understand substrate ubiquitination catalysed by the APC/C-UbcH10 pair, we determined a threedimensional reconstruction of an APC/C Cdh1 -substrate complex (APC/C Cdh1.Hsl1 ) with a UbcH10-ubiquitin conjugate. Because of the low affinity of APC/C-UbcH10-ubiquitin interactions 4 , to facilitate generation of APC/C Cdh1.Hsl1.UbcH10-Ub complexes suitable for cryo-EM, we fused the LR tail of Ube2S to the C terminus of UbcH10 (UbcH10 LR ) (Extended Data Fig. 1c ). This approach is similar to that used to target the heterologous E2 Ube2G2 to the APC/C 28 . The UbcH10 LR fusion protein exhibited a 100-fold slower dissociation rate and a tenfold higher affinity for the APC/C (Extended Data Table 3 ). Competition and mutagenesis analyses indicated that the UBC domain of UbcH10 LR binds the physiological site on the APC/C (Extended Data Fig. 4b, c) . Ubiquitination assays showed that UbcH10 LR and UbcH10 had indistinguishable activity (Extended Data Fig. 4d ).
The APC/C Cdh1.Hsl1.UbcH10-Ub complex was determined to 4.1 Å resolution (Extended Data Fig. 2c and Extended Data Table 1b ). Similar to APC/C Cdh1.Emi1 , three-dimensional classification revealed both ternary (coactivator-bound) and apo states (Extended Data Fig. 6a Fig. 2f) Fig. 6a, cycle 2) . Subjecting a major three-dimensional class for further classification generated a three-dimensional class with clearly resolved UbcH10 density (Extended Data Fig. 6a , cycle 3, class 5, and Extended Data Fig. 6b, c) . This structural class was suitable for docking UbcH10 coordinates (Fig. 4a, b) and is representative of other APC/C-UbcH10 conformational states (Extended Data Fig. 6d, e) . Relative to APC/C Cdh1.Emi1 , Apc2 CTD -Apc11 RING tilts slightly at the Apc2 NTD -Apc2 CTD interface (Extended Data Fig. 5f ), and Apc11 RING tilts relative to Apc2 CTD (Fig. 4c ). UbcH10 and Apc11 RING interact through a canonical E2-RING mechanism 26 , thus docking of UbcH10-Apc11 RING was guided by crystal structures of RING-UbcH5-ubiquitin complexes 29, 30 (Fig. 4a, b) . Importantly, this showed that density for ubiquitin was not visible in the EM map, indicating that the ubiquitin moiety is flexible (Figs 4a, b and 5a). Consistent with this conclusion, a reconstruction of an APC/C Cdh1.Hsl1.Apc11-UbcH10 fusion complex (Extended Data Figs 1b and 2d and Extended Data Table 1b), and a negative-stain structure of APC/C Cdh1.Hsl1 with a huge excess of UbcH10, showed that the shape of the UbcH10-assigned density resembled the UbcH10-ubiquitin density in the APC/C Cdh1.Hsl1.UbcH10-Ub map (Extended Data Figs 6c and 7) .
Since UbcH10 and Apc11 RING interact through a canonical E2-RING interface (Fig. 4a, b) , the APC/C probably stimulates the intrinsic catalytic activity of UbcH10-ubiquitin 31 by promoting a closed conformation that primes the UbcH10-ubiquitin thioester bond 15, 29, 30, [32] [33] [34] [35] [36] . In agreement with this, mutation of Ile36 that contacts Apc11
RING (refs 29, 30, 34) and Ile44 that contacts UbcH10 (refs 15, 29, 30, 32, 34) (Fig. 5a) ablates APC/C-catalysed ubiquitination (Extended Data Fig. 4e, f) . Nevertheless, the absence of EM density for the ubiquitin moiety of the UbcH10 LR -ubiquitin conjugate indicates that APC/C does not stabilize a static closed UbcH10-ubiquitin conformation 29, 30, 34 . Modelling shows that only Apc11 RING would interact with ubiquitin in the closed UbcH10-ubiquitin conformation (Fig. 5a ), whereas in crystal structures of RINGUbcH5-ubiquitin conjugates where ubiquitin is static, either a second RING subunit 29, 30 or a non-RING element 34 also contact ubiquitin to enhance catalytic efficiency. The APC/C is reminiscent of other single domain RING and U-box E3s that bias the E2-ubiquitin conformation from multiple extended states to the closed state 33, 37 . An interesting possibility is that substrate initiation motifs that promote lysine ubiquitination 38 may induce a closed UbcH10-ubiquitin conformation.
Defining target lysine ubiquitination
The APC/C Cdh1.Hsl1.UbcH10-Ub model shows that the UbcH10 catalytic Cys is some 40 Å from the C terminus of a D box at the D-box receptor 39 ( Fig. 5a ). An extended linker of ten residues would place a lysine C-terminal to the D box at the UbcH10-ubiquitin catalytic site (Fig. 5a) . Consistent with this, peptides with a lysine at positions K10, K13 and K18 relative to the D box were ubiquitinated, but not peptides with lysines at K1, K4 and K7 (Fig. 5b, c) . Peptides modelled on known 
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APC/C substrates, geminin (Lys50, equivalent to K18 (ref. 38)) and cyclin B (Lys64, equivalent to K13), were also ubiquitinated.
Conclusions
The atomic structure of the APC/C provides a quantitative framework for understanding APC/C mechanisms and the basis for future studies to investigate mechanisms of control by phosphorylation and the MCC. We speculate that in the APC/C Cdc20 complex inhibited by MCC, the second C-box receptor of the Apc8 homo-dimer may bind the Cdc20 subunit of the MCC 3, 40 . TAME is an Ile-Arg dipeptide APC/C inhibitor 41 . Its proposed mechanism is to inhibit coactivator association by competing for the IR tail-binding site on Apc3. The homology of the C-box receptor of Apc8 and the IR tail-receptor of Apc3 suggests that TAME may also disrupt C-box-APC/C interactions, a notion consistent with the more important role of the C box for APC/C activity and cell viability 20 .
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METHODS
No statistical methods were used to predetermine sample size. Cloning, expression and purification of recombinant human APC/C. The genes for recombinant human APC/C Cdh1.Emi1 were cloned into a modified MultiBac system as described previously 42 . Two pU2 plasmids were prepared: pU2-1 harbouring genes for Apc1 and Apc11, and pU2-2 containing genes for Apc5, Apc8, Apc10, Apc13 and Apc15. Two pF2 plasmids were prepared: pF2-1 harbouring genes for Apc3, Apc6, Apc7, Apc12 and Apc16, and pF2-2 containing genes for Apc2, Apc4, Cdh1 and Emi1. A C-terminal tev-cleavable double Strep-II tag was added to Apc4 for purification of the complex. Two bacmids were prepared from these four plasmids, resulting in two viruses harbouring all 16 genes with each gene flanked by its own promoter and terminator. The APC/C Cdh1.Emi1 ternary complex was co-expressed from these two viruses in High 5 insect cells. The complex was purified by a combination of Strep-Tactin (Qiagen), anion exchange chromatography Mono Q and Superose 6 size-exclusion chromatography (GE Healthcare) similar to ref. 42 .
APC/C Cdh1.Hsl1.Apc11-UbcH10 was cloned, expressed and purified as described previously 4 , except that Apc11 was replaced with Apc11 fused to UbcH10 (C114K) at its C terminus by a 30-residue linker of GSA repeats. A similar version of APC/C Cdh1.Hsl1.Apc11-UbcH10 fusion complex was also prepared using wild-type UbcH10 instead of UbcH10 (C114K) for activity studies.
UbcH10
LR was constructed by fusion of residues 154-222 of Ube2S to the C terminus of UbcH10 (C114K) in the pET28 plasmid. An N-terminal His 6 -tev site was added to UbcH10 LR . In the purified ubiquitin and UbcH10 LR proteins the His 6 tag was retained on ubiquitin, but cleaved from UbcH10
LR . The UbcH10 LR -ubiquitin conjugate was generated as previously described 4 with minor modifications. UbcH10 LR (200 mM) was incubated with His 6 -tagged ubiquitin (400 mM) at 25 uC for 16 h in a buffer containing 5 mM UBA1, 3 mM ATP, 5 mM MgCl 2 , 0.8 mM TCEP, 150 mM NaCl, 50 mM Tris-HCl (pH 10.0). Additional 2 mM ATP and 2 mM UBA1 were added to the reaction and incubated at 25 uC for another 8 h. The UbcH10 LR -ubiquitin conjugate was separated from unconjugated UbcH10
LR by Ni-NTA and separated from free ubiquitin by S75 sizeexclusion chromatography (GE Healthcare). APC/C Cdh1.Hsl1 was purified as described previously 4 . The purified APC/C Cdh1.Hsl1 was concentrated to 3 mM. APC/C Cdh1.Hsl1.UbcH10-Ub was reconstituted by incubating APC/C Cdh1.Hsl1 with UbcH10 LR -ubiquitin conjugate in a 1:3 molar ratio on ice for 30 min in buffer of 20 mM HEPES (pH 8.0), 150 mM NaCl, 1 mM DTT. Just before applying to EM grids, the sample was cross-linked with 0.03% glutaraldehyde, and incubated on ice for 40 min. The reaction was quenched by adding 40 mM Tris-HCl (pH 8.0). The quenched sample was incubated on ice for 30 min before further purification with size-exclusion Superose 6. A similar UbcH10 LR protein was made by using wild-type UbcH10 for use in activity tests. Surface plasmon resonance experiments for UbcH10 LR and APC/C were performed as described previously 4 . The Y91A and S123G mutants of UbcH10 and UbcH10LR were prepared as for wild-type UbcH10.
For ubiquitination reactions, APC/C and its variants with mutant subunits (Apc1 and Apc8) were cloned, expressed and purified as for apo APC/C 42 by replacing the target subunit with its mutant. These included APC/C with Apc1 T121A/S151A/S163A , Cdh1 S40A/S151A/S163A , Cdh1 S40A/T121A/S163A , Cdh1 S40A/T121A/S151A , Cdh1
S40A/T121A/S151A/S163A and Cdh1
T32A/S36A/S70A/S138A/S146A . All Cdh1 and its mutations were expressed in High Five insect cells. To purify Cdh1, the cells were lysed in a buffer of 50 mM Tris-HCl (pH 7.3), 500 mM NaCl, 20 mM imidazole (Buffer A), with a protease inhibitor cocktail. After loading, the Ni-NTA column was washed with ten column volumes of buffer A, followed by a gradient wash to 200 mM imidazole in buffer A and further washing with ten column volumes of 200 mM imidazole in buffer A. The protein was eluted in buffer B of 300 mM imidazole (pH 7.3), 500 mM NaCl. Cdh1 was finally purified using S-200 size exclusion chromatography in 20 mM HEPES (pH 7.0), 200 mM NaCl, 1 mM DTT.
Human ubiquitin complementary DNA was cloned into a pET28 plasmid with an N-terminal His 6 tag and TEV cleavage site. On the basis of this plasmid, ubiquitin I36A and ubiquitin I44A mutants were prepared. Wild-type and mutant ubiquitin were expressed in B834 rare2 strain and purified by Ni-NTA and S75 sizeexclusion chromatography (GE Healthcare).
APC/C ubiquitination assays. Human APC/C and its different mutant derivatives, UBA1, UbcH10 and its mutants, Ube2S, ubiquitin and its mutants, and yeast Hsl1 were buffer exchanged into 20 mM HEPES (pH 8.0), 150 mM NaCl, 1 mM DTT. Human Cdh1 and its mutants were in 20 mM HEPES (pH 7.0), 200 mM NaCl, 1 mM DTT. Ubiquitination assays were performed as described 4 . For the UbcH10 competition assays, UbcH10 C114K and UbcH10 C114K-LR at the concentrations 0.001, 0.01, 0.1, 1 and 10 mM were used to compete with UbcH10 (0.1 mM). Cdh1 was at 20 nM. To test the UbcH10-RING domain interface, the following UbcH10 and UbcH10
LR mutants were prepared and tested: Y91A and S123G. Single time point assays were at 10 min. Cdh1 phosphorylation assays. CDK2-dependent phosphorylation of Cdh1 and its mutants was performed in buffer containing 50 mM HEPES (pH 8.0), 10 mM MgCl 2 , 2 mM ATP, 10 mM NaF, 10 mM glycerol phosphate and 150 mM NaCl. The reactions were incubated at 23 uC for 30 min with 500 nM of Cdh1 and 50 nM of active phosphorylated CDK2-cyclin A3. The phosphorylation was terminated using the CDK1/2 inhibitor (Calbiochem). Non-CDK2-treated Cdh1 samples were set up in parallel with phosphorylating reactions by adding buffer instead of CDK2-cyclin A3. The activity assays were performed as described for ubiquitination assays. Peptide assays. Peptides for D-box lysine distance analysis were synthesized by Designer BioScience. The peptides were modified by N-terminal biotinylation. Peptides used were the following: Pep-1K (EQRPRTALGDISNSKASGS); Pep-4K (EQRPRTALGDISNSAGSKASGS); Pep-7K (EQRPRTALGDISNSAGSAGSKA SGS); Pep-10K (EQRPRTALGDISNSAGSAGSAGSKASGS); Pep-13K (EQRPR TALGDISNSAGSAGSAGSAGSKASGS); Pep-18K (EQRPRTALGDISNSAGSA GSAGSAGSAGSGSKASGS); GEM-K50 (EQRPRTALGDISNSASGSLVGRENE LSAGLSKRRHR); and CycB-K64 (GLRPRTALGDIGNRVSEQLQARMPMRKE ARPSATGS). The peptides were dissolved at a concentration of 6.25 mM in 100% dimethylsulfoxide (DMSO). The ubiquitination assays were performed as described above except that 125 mM of peptide instead of Hsl1 was used as substrate. Previous work showed that at 100 mM, D-box-only peptides bind the D-box receptor of APC/C Cdh1 (refs 43, 44) . The reactions were separated in 4-12% NuPAGE Bis-Tris gels (Life Technology) by 60 V for 2 h, followed by 150 V for 30 min for better resolution of peptides and ubiquitination products. After blotting, the membranes were blocked in 10% non-fat dry milk in PBS overnight at 4 uC. After washing the blot four times with PBS-2% Tween 20 buffer, ubiquitinated peptide products were visualized by western blotting with PBS-buffered streptavidin-HRP (Sigma) with 1% bovine serum albumin. Electron microscopy. Freshly purified recombinant human APC/C complexes (APC/C Cdh1.Emi1
, APC/C Cdh1.Hsl1.UbcH10-Ub and APC/C Cdh1.Hsl1.Apc11-UbcH10 ) were first visualized by negative-stain electron microscopy to check homogeneity. Complexes were then diluted to ,200 mg ml 21 and aliquots of 2 ml were applied to Quantifoil R2/2 grids coated with a second layer of home-made thin carbon film (estimated to be ,50 Å thick), treated with a 9:1 argon:oxygen plasma for 20 s before use. The grids were incubated for 30 s at 4 uC and 100% humidity and then blotted for 6 s and plunged into liquid ethane using an FEI Vitrobot III. The grids were loaded into an FEI Tecnai Polara electron microscope at an accelerating voltage of 300 kV. Images were taken manually using low-dose mode at a nominal magnification of 378,000 (yielding a pixel size of 1.36 Å per pixel) for APC/C Cdh1.Emi1 and APC/C Cdh1.Hsl1.Apc11-UbcH10 , and 359,000 (yielding a pixel size of 1.77 Å per pixel) for APC/C Cdh1.Hsl1.UbcH10-Ub . Images were recorded using an FEI Falcon II direct electron detector with a defocus range of ,2.5-4 mm. Each image was exposed for 2 s at dose rate of 27 electrons per square ångström per second at a nominal magnification of 378,000 and 16 electrons per square ångström per second at a nominal magnification of 359,000. Thirty-four movie frames were recorded for each image as previously described 45 . To prepare a negative-stain reconstruction of APC/C Cdh1.Hsl1 -UbcH10 (with excess wild-type UbcH10), we incubated freshly purified APC/C Cdh1.Hsl (0.04 mM) with a 1,500-fold excess of UbcH10 (60 mM, 200-fold in excess of dissociation constant K d ) for 1 h on ice. Images were collected on an FEI Spirit electron microscope at an accelerating voltage of 120 kV at 21.5 mm defocus. The map was reconstructed using RELION without contrast transfer function correction. Image processing. All movie frames were first aligned by the motioncorr program 46 before subsequent processing. Contrast transfer function parameters were calculated with CTFFING3 (ref. 47) . Particles in 264 pixels 3 264 pixels (or 200 pixels 3 200 pixels for data collected at 359,000 magnification) were initially selected automatically by e2boxer.py in EMAN2 (ref. 48 ) from a small portion of the same data set (typically ,300 micrographs). After twodimensional classification using RELION 49 , ten images in different views were selected from the two-dimensional averages and used as reference for automatic particle picking for the whole data set by RELION 1.3 (ref. 50) . The following procedures were performed in RELION to exclude bad particles from the final ARTICLE RESEARCH reconstruction. First, particles in each micrograph were displayed and manually screened to delete wrongly picked ice contamination. Second, extracted particles were sorted by similarity to reference images, and particles with low z-scores were deleted (roughly 10% particles were deleted in this step). Third, two-dimensional classification was performed and particles in bad classes (with poor structural features) were removed (roughly 10-20% of particles were deleted in this step). The resultant particles were then used for three-dimensional classifications. Conformational heterogeneity and remaining bad particles were excluded from the final reconstruction in this step. A summary of particles used for final refinements is listed in Extended Data Table 1c .
Beam-induced particle motion was corrected using statistical movie processing in RELION as previous described 45 . For APC/C, a running average of nine movie frames for frames within the first 32-electron dose and a standard deviation of one pixel for the translational alignment were used. This step improved the resolution from 4.2 Å to 3.9 Å . Following this, particle polishing in RELION 1.3 was used to improve the resolution further 51 . This program fits all movie frames as linear tracks, considering movements of neighbouring particles to improve signal for smaller particles. Furthermore, each frame is weighted by a B-factor (estimated by each frame reconstruction) to treat radiation damage problems. Particle polishing was then used to improve the resolution from 3.9 Å to 3.6 Å . All resolution estimations were from gold-standard Fourier shell correlation (FSC) calculations to avoid over-fitting and reported resolutions are based on the FSC 5 0.143 criterion 52, 53 . Final FSC curves were calculated using a soft spherical mask (with a five-pixel fall-off) of the two independent reconstructions. To visualize highresolution details, all density maps were corrected for modulation transfer function of the detector and sharpened by applying negative B-factors, estimated using automated procedures 52 . Motion correction was performed after three-dimensional classification for APC/C Cdh1.Emi1
, which showed ,60% ternary complex and ,40% apo state APC/C. For APC/C Cdh1.Hsl1.UbcH10-Ub and APC/C Cdh1.Hsl1.Apc11-UbcH10 , all particles were refined against one model and motion corrected as described above. The polished particles were used for three-dimensional classification as shown in Extended Data Figs 6 and 7. The first cycle of classification was done by global search and a sampling angular interval of 7.5u to sort out large conformational changes; cycles 2-4 were executed by local search within 15u and a smaller sampling angular interval of 3.7u. Three-dimensional classifications were run for 25 iterations with class number set at 10 and regularization parameter T set at 4.
To further improve the density map of flexible parts (RING domain and UbcH10) in the complexes, a soft mask was used for local alignment during refinement. A soft mask was generated according to combined coordinates of Apc1/Apc2/Apc4/Apc5/Apc11/UbcH10 (approximately half of the mass) and a restrained angular search of 3u was used. Local resolution was estimated using ResMap 54 . Model building of APC/C. Modelling of the structures of APC/C was performed in COOT 55 . Initially, available crystal structures and homology models as described in our previous work 4 were fitted into the cryo-EM map in Chimera. These structures included (1) crystal structures of human Apc10 (residues 2-162, Protein Data Bank (PDB) accession number 1JHJ) 56 , (2) N-terminal seven helices of Apc7 (residues 21-166, PDB accession number 3FFL) 57 , (3) Schizosaccharomyces pombe Cut9-Hcn26 complex (Apc6-Apc12 homologue, PDB accession number 1XPI) 58 , (4) N-terminal dimerization domains of Encephalitozoon cuniculi Cdc27 (Apc3 homologue, PDB accession number 3KAE) 59 , (5) S. pombe Cut23 (Apc8 homologue, PDB accession number 3ZN3) 60 , (6) Cdh1-D-KEN (PDB accession number 4BH6) 39 , (7) Apc5 TPR domain and C-terminal TPR helices of Apc3, Apc8 and Apc7 (model using the crystal structure of S. pombe Cut9 as template), (8) crystal structures of Apc4 and Apc5 NTD (residues 1-160) (unpublished data) and (9) NMR structure of Emi1 ZBR domain 13 (PDB accession number 2M6N) and Apc11 RING domain 26 (PDB accession number 4R2Y). For Apc2-Apc11 N , the structure was modelled using a crystal structure of Cul1 (PDB accession number 1U6G) 61 as a template. For Apc1 PC repeats, the structure was predicted with I-Tassar 62 using the PC domain structure of Rpn2 (PDB accession number 4ADY) 63 as a reference. All fitted structures were rebuilt according to the cryo-EM map. The majority of Apc1, small subunits (Apc13, Apc15, Apc16), IR C-terminal tails of Apc10 and Cdh1, N-terminal domain of Cdh1 (Cdh1 NTD ) and some loops not seen in crystal structures and homology were built ab initio. Details are given in Extended Data Table 2 .
The model was refined by REFMAC version 5.8 (ref. 64) . A REFMAC weight of 0.04 was defined by cross-validation using half reconstructions 65 . The resolution limit for refinement was set at 3.5 Å . All high-resolution crystal structures or 
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Extended Data Figure 3 | Apc1 structure and the TPR lobe interacts with multiple subunits. a, Cartoon of Apc1 colour-ramped from blue to red for the N to C termini. Insertions that interact with Apc2, Apc8 and Apc10 are labelled. Apc1 Mid adopts a novel architecture. b, TPR lobe with TPR subunits shown as surface representations, with the small TPR-accessory subunits (Apc12, Apc13, Apc15 and Apc16), a segment of Apc5, IR tails of Cdh1 and Apc10, and the Cdh1 C box that interact with the TPR lobe are shown as cartoons. The N termini of Apc12, Apc13 and Apc15 are buried. The eight structurally homologous and symmetry-equivalent sites on the TPR lobe that bind Apc13, Apc16 and Apc5 are indicated and shown in detail in c. The view is similar to Fig. 1a . c, The eight TPR subunits interact with Apc13, Apc16 and Apc5 mainly through contacts to four conserved aromatic residues present on most TPR subunits (Y308, Y309, W302, Y322 of Apc6 (panels 5 and 6)). d, Sequence of the ordered region of Cdh1 NTD bound to Apc1 and Apc8 (ordered regions shown as lines and a-helices). Critical Apc1 and Apc8 contact residues are indicated with green and blue arrows. Phosphorylation sites are indicated with red arrows. 61 ). This is due to a 70u rotation within cullin repeat 3 (between helices A-B and C-D-E), and a ,20u rotation around the 4HB-cullin repeat 3 interface. Similar less pronounced structural variations are observed within the CRL family. d, Apc2-Apc11 (this study). e, Cul1-Rbx1 (PDB accession number 1LDK) 61 . . a, The three-dimensional classification started with 97,999 motion-corrected particles, which were divided into five classes. The resultant classes were grouped into three categories: (1) 80.6% in the active ternary state with coactivator and substrate (Hsl1); (2) 9.3% in the apo state; and (3) 10.1% in a hybrid state. Particles in the active ternary state (reconstructed to an overall resolution of 4.3 Å ) were subjected to cycle 2 classification with ten classes. UbcH10 density in the resultant classes is indicated with circles. b, Classes with UbcH10 density in cycle 2 classification are superimposed, showing variability of UbcH10. c, Enlarged view of UbcH10 density. d, A negative-stain EM reconstruction of an APC/C Cdh1.Hsl1 complex at ,25 Å resolution with a 1,500-fold excess of UbcH10. The molecular surface is shown as a mesh representation and the coordinates of the APC/C Cdh1.Hsl1.UbcH10-Ub were docked into the EM reconstruction. The
